{"text": ["Eli", "Lilly's", "Mirikizumab", "Maintains", "Symptomatic", "Remission", "for", "Two", "Years", "In", "Ulcerative", "Colitis", "Patients"], "created_at": "2021-10-01 15:18:55"}
{"text": ["Pharma", "Stock", "Roundup:", "MRK", "to", "Buy", "XLRN,", "ABBV", "Gets", "FDA", "Nod", "for", "Migraine", "Drug", "&", "More"], "created_at": "2021-10-01 13:18:01"}
{"text": ["At", "Week", "104,", "75%", "of", "Patients", "with", "Ulcerative", "Colitis", "Taking", "Mirikizumab", "Maintained", "Symptomatic", "Remission", "in", "Phase", "2", "Study"], "created_at": "2021-10-01 13:00:00"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "Eli", "Lilly,", "Costco,", "Applied", "Materials,", "Illumina", "and", "Norfolk", "Southern", "Corp"], "created_at": "2021-10-01 10:47:10"}
